Full disclosure--out-of-pocket costs as side effects.
Publication
, Journal Article
Ubel, PA; Abernethy, AP; Zafar, SY
Published in: N Engl J Med
October 17, 2013
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
October 17, 2013
Volume
369
Issue
16
Start / End Page
1484 / 1486
Location
United States
Related Subject Headings
- United States
- Therapeutics
- Neoplasms
- Insurance Carriers
- Humans
- Health Expenditures
- Health Care Costs
- General & Internal Medicine
- Financing, Personal
- Disclosure
Citation
APA
Chicago
ICMJE
MLA
NLM
Ubel, P. A., Abernethy, A. P., & Zafar, S. Y. (2013). Full disclosure--out-of-pocket costs as side effects. N Engl J Med, 369(16), 1484–1486. https://doi.org/10.1056/NEJMp1306826
Ubel, Peter A., Amy P. Abernethy, and S Yousuf Zafar. “Full disclosure--out-of-pocket costs as side effects.” N Engl J Med 369, no. 16 (October 17, 2013): 1484–86. https://doi.org/10.1056/NEJMp1306826.
Ubel PA, Abernethy AP, Zafar SY. Full disclosure--out-of-pocket costs as side effects. N Engl J Med. 2013 Oct 17;369(16):1484–6.
Ubel, Peter A., et al. “Full disclosure--out-of-pocket costs as side effects.” N Engl J Med, vol. 369, no. 16, Oct. 2013, pp. 1484–86. Pubmed, doi:10.1056/NEJMp1306826.
Ubel PA, Abernethy AP, Zafar SY. Full disclosure--out-of-pocket costs as side effects. N Engl J Med. 2013 Oct 17;369(16):1484–1486.
Published In
N Engl J Med
DOI
EISSN
1533-4406
Publication Date
October 17, 2013
Volume
369
Issue
16
Start / End Page
1484 / 1486
Location
United States
Related Subject Headings
- United States
- Therapeutics
- Neoplasms
- Insurance Carriers
- Humans
- Health Expenditures
- Health Care Costs
- General & Internal Medicine
- Financing, Personal
- Disclosure